198 related articles for article (PubMed ID: 28893354)
21. [Prevalence of cytotoxicity effectors in nosocomial Pseudomonas Aeruginosa strains].
Kuznetsova MV; Maksimova AV; Karpunina TI; Demakov VA
Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):9-14. PubMed ID: 25816507
[TBL] [Abstract][Full Text] [Related]
22. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene.
Kainuma A; Momiyama K; Kimura T; Akiyama K; Inoue K; Naito Y; Kinoshita M; Shimizu M; Kato H; Shime N; Fujita N; Sawa T
J Infect Chemother; 2018 Aug; 24(8):615-622. PubMed ID: 29628388
[TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiology, resistance, and virulence properties of Pseudomonas aeruginosa cross-colonization clonal isolates in the non-outbreak setting.
Hu P; Chen J; Chen Y; Zhou T; Xu X; Pei X
Infect Genet Evol; 2017 Nov; 55():288-296. PubMed ID: 28911852
[TBL] [Abstract][Full Text] [Related]
24. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
Jarjees KK
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
[TBL] [Abstract][Full Text] [Related]
25. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
[TBL] [Abstract][Full Text] [Related]
26. Study on Virulence Genes of Type III Secretion System of Pseudomonas aeruginosa in Xinjiang Province.
Yi H; Sun Q; Wang X; Liu Y; Feng N; Zhang L; Song W; Shang X; Li X; Ma X
Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383413
[TBL] [Abstract][Full Text] [Related]
27. Detection of Virulence Factors and Antibiotic Resistance Pattern of Clinical and Intensive Care Unit Environmental Isolates of Pseudomonas aeruginosa.
Zarei O; Mahmoudi H; Bardbari AM; Karami P; Alikhani MY
Infect Disord Drug Targets; 2020; 20(5):758-762. PubMed ID: 31889501
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial resistance, biofilm-forming ability and virulence potential of Pseudomonas aeruginosa isolated from burn patients in northern Iran.
Asadpour L
J Glob Antimicrob Resist; 2018 Jun; 13():214-220. PubMed ID: 29421318
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
[TBL] [Abstract][Full Text] [Related]
30. Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis.
Choy MH; Stapleton F; Willcox MDP; Zhu H
J Med Microbiol; 2008 Dec; 57(Pt 12):1539-1546. PubMed ID: 19018027
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.
Garey KW; Vo QP; Larocco MT; Gentry LO; Tam VH
J Chemother; 2008 Dec; 20(6):714-20. PubMed ID: 19129069
[TBL] [Abstract][Full Text] [Related]
32. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
33. Characterization of clinical extensively drug resistant Pseudomonas aeruginosa from a Chinese teaching hospital.
Zou M; Wang H; Shui J; Li J; Hu Y; Dou Q; Yan Q; Liu WE
J Infect Dev Ctries; 2018 Oct; 12(10):835-841. PubMed ID: 32004151
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones.
Recio R; Sánchez-Diener I; Viedma E; Meléndez-Carmona MÁ; Villa J; Orellana MÁ; Mancheño M; Juan C; Zamorano L; Lora-Tamayo J; Chaves F; Oliver A
Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):671-678. PubMed ID: 31823150
[TBL] [Abstract][Full Text] [Related]
35. Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.
Agnello M; Wong-Beringer A
PLoS One; 2012; 7(8):e42973. PubMed ID: 22905192
[TBL] [Abstract][Full Text] [Related]
36. Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.
Juan C; Peña C; Oliver A
J Infect Dis; 2017 Feb; 215(suppl_1):S44-S51. PubMed ID: 28375513
[TBL] [Abstract][Full Text] [Related]
37. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.
Sawa T; Shimizu M; Moriyama K; Wiener-Kronish JP
Crit Care; 2014 Dec; 18(6):668. PubMed ID: 25672496
[TBL] [Abstract][Full Text] [Related]
38. The Frequency of Exotoxin A and Exoenzymes S and U Genes Among Clinical Isolates of Pseudomonas aeruginosa in Shiraz, Iran.
Yousefi-Avarvand A; Khashei R; Sedigh Ebrahim-Saraie H; Emami A; Zomorodian K; Motamedifar M
Int J Mol Cell Med; 2015; 4(3):167-73. PubMed ID: 26629485
[TBL] [Abstract][Full Text] [Related]
39. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.
Sánchez-Diener I; Zamorano L; López-Causapé C; Cabot G; Mulet X; Peña C; Del Campo R; Cantón R; Doménech-Sánchez A; Martínez-Martínez L; Arcos SC; Navas A; Oliver A
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923877
[TBL] [Abstract][Full Text] [Related]
40. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
